Sanofi SNY
NASDAQ SNY
$42.48 -0.66 (-1.53%)
At close: Sep 18, 2026 · 4:00 PM EDT

Sanofi (SNY) Other Non Operating Income (2011 - 2016)

Sanofi's (SNY) quarterly Other Non Operating Income came in at -$44.3 million in Q4 2016, down 125.08% year-over-year from $176.5 million in Q1 2016, and down 46.89% quarter-over-quarter from -$30.1 million in Q3 2016.

Analysis

Sanofi (SNY) Other Non Operating Income (2011 - 2016) Analysis & Trends

Sanofi has disclosed Other Non Operating Income across 6 years of filings, most recently posting -$44.3 million for Q4 2016.

  • In Q4 2016, Other Non Operating Income fell 125.08% year-over-year to -$44.3 million; the TTM figure through Dec 2016 stood at -$149.3 million (down 142.06% YoY), while the FY2016 annual figure was -$149.5 million, down 353.86% from the prior year.
  • Other Non Operating Income came in at -$44.3 million for Q4 2016 at Sanofi, down from -$30.1 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $679.2 million in Q4 2013 to a low of -$378.7 million in Q4 2014.
  • Average Other Non Operating Income over 5 years is $20.9 million, with a median of -$4.9 million recorded in 2014.
  • Year-over-year, Other Non Operating Income jumped 426.04% in 2012 and sank 2931.16% in 2016.
  • Over 5 years, Other Non Operating Income stood at -$249.0 million in 2012, then surged by 372.76% to $679.2 million in 2013, then plunged by 155.76% to -$378.7 million in 2014, then surged by 146.6% to $176.5 million in 2015, then sank by 125.08% to -$44.3 million in 2016.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were -$44.3 million in Q4 2016, -$30.1 million in Q3 2016, and -$42.9 million in Q2 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -44.27 Mn
Sep 30, 2016 -30.14 Mn
Jun 30, 2016 -42.94 Mn
Mar 31, 2016 -31.99 Mn
Dec 31, 2015 176.47 Mn
Sep 30, 2015 100.11 Mn
Jun 30, 2015 77.36 Mn
Mar 31, 2015 1.13 Mn
Dec 31, 2014 -378.70 Mn
Sep 30, 2014 -59.73 Mn
Jun 30, 2014 -170.11 Mn
Mar 31, 2014 -10.96 Mn
Dec 31, 2013 679.18 Mn
Sep 30, 2013 90.10 Mn
Jun 30, 2013 99.24 Mn
Mar 31, 2013 54.13 Mn
Dec 31, 2012 -249.00 Mn
Sep 30, 2012 107.55 Mn
Jun 30, 2012 93.80 Mn
Mar 31, 2012 -43.27 Mn